Viking Therapeutics: Mysterious GLP-1 Player With A Key Catalyst (Q2 Earnings) (VKTX)
· seekingalpha.com
Viking Therapeutics stock holds as GLP-1 obesity drug competition heats up. Read the latest analysis on earnings here.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...